Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $93.25 | $23.70 | 293.45% | 202.72x | 156.28x | 12.66x | 15.69x | 1.44x | $119.79M | 1.23% | $637.99M | 6.11 | $9.91B | -1,443.55 | ||
| LQDA | LIQUIDIA CORP | $81.45 | $17.33 | 369.88% | 339.38x | 23.71x | 24.89x | 66.71x | 1.67x | $41.15M | 0.57% | $108.58M | 1.23 | $7.20B | 134.44 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.62 | $2.77 | 211.08% | 123.14x | 75.68x | 4.67x | 114.38x | 1.18x | $47.52M | 3.24% | $13.01M | 0.08 | $1.63B | 30.60 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $312.79 | $91.49 | 241.90% | 71.74x | 41.76x | 9.70x | 38.83x | 1.49x | $641.34M | 1.54% | $1.08B | 8.09 | $43.02B | 46.54 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $65.38 | $16.98 | 284.96% | 66.71x | 51.21x | 6.63x | 8.30x | 1.81x | $164.23M | 3.28% | $605.69M | 7.92 | $4.85B | 43.50 | ||
| KRYS | KRYSTAL BIOTECH INC | $371.24 | $93.52 | 296.97% | 47.90x | 47.42x | 26.06x | 8.57x | 2.29x | $237.38M | 2.18% | $1.28B | 43.59 | $10.45B | 48.85 | ||
| RPRX | ROYALTY PHARMA PLC | $57.96 | $39.11 | 48.21% | 30.35x | 10.87x | 10.37x | 3.36x | 0.65x | $2.34B | 9.25% | $9.94B | 22.75 | $41.75B | 35.88 | ||
| VCEL | VERICEL CORP | $48.31 | $8.96 | 439.28% | 112.35x | 100.21x | 8.40x | 6.93x | 2.36x | $47.49M | 1.94% | $356.23M | 7.02 | $2.45B | 60.67 | ||
| ADMA | ADMA BIOLOGICS INC | $9.27 | $9.02 | 2.74% | 13.43x | 11.05x | 4.29x | 5.50x | 0.56x | $107.90M | 4.93% | $390.33M | 1.65 | $2.21B | 9.97 | ||
| HALO | HALOZYME THERAPEUTICS INC | $78.62 | $69.94 | 12.42% | 26.56x | 9.47x | 6.16x | 42.46x | 0.47x | $667.65M | 7.19% | $219.64M | 1.86 | $11.16B | 17.89 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.97 | $39.57 | 51.56% | 42.84x | 16.23x | 3.56x | 1.87x | 0.61x | $767.06M | 6.64% | $6.21B | 32.27 | $9.95B | 20.62 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $246.91 | $48.19 | 412.34% | 525.34x | 9.55x | 3.44x | 3.42x | 1.78x | $1.30B | 8.49% | $4.53B | 73.22 | $19.05B | 28.22 | ||
| ASND | ASCENDIS PHARMA A | $275.43 | $79.29 | 247.38% | 29.19x | 18.76x | 16.80x | 29.80x | 2.97x | $52.94M | 0.31% | $574.09M | 9.24 | $17.49B | 187.53 | ||
| TGTX | TG THERAPEUTICS INC | $59.06 | $20.43 | 189.07% | 18.34x | 42.50x | 12.18x | 15.50x | 5.13x | -$14.19M | -0.17% | $583.13M | 4.04 | $9.35B | 62.33 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $322.61 | $92.54 | 248.63% | 40.84x | 35.55x | 23.37x | 6.48x | 2.06x | $122.22M | 1.91% | $997.32M | 50.16 | $6.80B | 30.16 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.21 | $35.12 | 8.81% | 15.10x | 10.47x | 2.46x | 2.43x | 0.57x | $341.79M | 15.47% | $910.35M | 15.75 | $1.78B | 7.52 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.12 | $8.80 | -75.92% | 7.85x | -7.17x | 1.99x | 2.32x | 0.09x | $7.24M | 5.94% | $52.93M | 0.92 | $69.10M | 4.46 | ||
| TECH | BIO-TECHNE CORP | $71.15 | $16.42 | 333.23% | 100.21x | 34.10x | 9.19x | 5.34x | 1.84x | $269.60M | 2.42% | $2.09B | 13.34 | $11.22B | 43.83 | ||
| UTHR | UNITED THERAPEUTICS CORP | $552.48 | $237.06 | 133.05% | 18.87x | 19.89x | 7.58x | 3.97x | 2.12x | $1.02B | 4.23% | $5.90B | 135.66 | $22.17B | 12.94 | ||
| EXEL | EXELIXIS INC | $57.10 | $30.49 | 87.30% | 18.30x | 17.55x | 6.21x | 7.41x | 1.31x | $917.69M | 6.22% | $1.94B | 7.49 | $14.30B | 13.54 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $496.50 | $164.66 | 201.54% | 29.19x | 25.40x | 10.33x | 6.51x | 2.13x | $3.71B | 2.94% | $19.36B | 76.20 | $122.51B | 22.71 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.47 | $12.54 | 151.00% | 17.39x | 15.80x | 6.44x | 3.80x | 3.25x | $208.13M | 5.41% | $1.01B | 8.28 | $3.10B | 9.25 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.49 | $2.41 | 44.72% | 14.54x | 14.75x | 2.14x | 3.38x | 0.98x | $4.11M | 1.46% | $82.33M | 1.03 | $213.99M | 10.07 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $667.95 | $427.33 | 56.31% | 15.69x | 14.19x | 4.66x | 2.23x | 1.06x | $4.11B | 5.92% | $31.42B | 302.15 | $69.77B | 12.14 | ||
| VCYT | VERACYTE INC | $59.30 | $7.47 | 694.21% | 53.42x | 53.48x | 8.71x | 3.52x | 11.28x | $155.34M | 3.29% | $1.34B | 16.90 | $4.51B | 39.17 | ||
| INCY | INCYTE CORP | $118.52 | $63.66 | 86.19% | 16.26x | 14.98x | 4.41x | 4.21x | 1.50x | $1.45B | 6.14% | $5.62B | 28.21 | $20.25B | 10.82 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $20.52 | $3.19 | 543.56% | 34.20x | 5.60x | 0.99x | 1.44x | 76.20x | $109.24M | 5.07% | $1.51B | 14.34 | $2.74B | 33.10 | ||
| MDXG | MIMEDX GROUP INC | $4.14 | $1.22 | 240.37% | 19.71x | -49.17x | 1.58x | 2.54x | 10.38x | $69.36M | 11.28% | $242.94M | 1.64 | $474.46M | 8.71 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.